Back to search

Article

A high-throughput microfluidic nano-immunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultra-low volume dried blood samples

2020-10-09

Abstract excerpt

Novel technologies are needed to facilitate large-scale detection and quantification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific antibodies in human blood samples. Such technologies are essential to support seroprevalence studies, vaccine clinical trials, and to monitor quality and duration of immunity. We developed a microfluidic nano-immunnoassay for the detection of anti-SARS-CoV-2...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fe71eb11-cb1c-59be-a6d7-d9b3cc3811e5
DOI
10.1101/2020.10.07.20208280
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A high-throughput microfluidic nano-immunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultra-low volume dried blood samplesDOI 10.1101/2020.10.07.20208280
Clinical sensitivity and specificity of a high-throughput microfluidic nano-immunoassay combined with capillary blood microsampling for the identification of anti-SARS-CoV-2 Spike IgG serostatusSemantic proximity
Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants.Semantic proximity
Rapid quantitative electrochemical detection of SARS-CoV-2 antibodies in plasma and dried blood spot samplesSemantic proximity
Microfluidic Nano-Scale qPCR Enables Ultra-Sensitive and Quantitative Detection of SARS-CoV-2Semantic proximity
A Rapid Saliva Test for Monitoring Immune Protection against SARS -CoV-2 and its VariantsSemantic proximity
Development of Nucleocapsid-Specific Monoclonal Antibodies for SARS-CoV-2 and Their ELISA Diagnostics on an Automatic Microfluidic DeviceSemantic proximity
Machine-learning-aided multiplexed nanobiosensor for COVID-19 population immunity profilingSemantic proximity
Nanoparticle-Supported, Rapid, and Electronic Detection of SARS-CoV-2 Antibodies and Antigens at Sub-Femtomolar LevelSemantic proximity
A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled bloodSemantic proximity
Enzyme immunoassay for SARS-CoV-2 antibodies in dried blood spot samples: A minimally-invasive approach to facilitate community- and population-based screeningSemantic proximity
Centrifugal microfluidic-based multiplex recombinase polymerase amplification assay for rapid detection of SARS-CoV-2Semantic proximity
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Semantic proximity
Select a neighboring publication to make it the new centre.